Analyst Price Target is $1.50
▲ +∞ Upside Potential
This price target is based on 1 analysts offering 12 month price targets for SonicShares Airlines, Hotels, Cruise Lines ETF in the last 3 months. The average price target is $1.50, with a high forecast of $1.50 and a low forecast of $1.50. The average price target represents a ∞ upside from the last price of $0.00.
Current Consensus is
The current consensus among 1 contributing investment analysts is to buy stock in SonicShares Airlines, Hotels, Cruise Lines ETF.
SonicShares Airlines, Hotels, Cruise Lines ETF
Tryp Therapeutics Inc., a clinical-stage biotechnology company, focuses on developing psilocybin-related molecules. The company's Psilocybin-For-Neuropsychiatric Disorders (PFN) program focuses on the development of synthetic psilocybin-related molecules as a new class of drug for the treatment of binge eating, chronic pain, and other indications. Its program candidate includes TRP-8803, a psilocybin-based drug product for the treatment of diseases with unmet medical needs through accelerated regulatory pathways. The company was formerly known as Artos Pharma Corp. and changed its name to Tryp Therapeutics Inc. in June 2020. Tryp Therapeutics Inc. was incorporated in 2019 and is based in Kelowna, Canada.